TAG ARCHIVES FOR international

8
Feb2013

Punxsutawney Phil predicted that spring will come early this year, so to celebrate we’ve brought together the latest stories in the world of research ethics! In this Research Ethics Roundup installment, learn about burgeoning discussion of the use of placebos in developing countries, recent reports of government agencies funding redundant protocols, and much more!

Ethical controversy in human subjects research: The use of placebo as a control in clinical trials is typically considered unethical if an effective treatment for the condition under study already exists. However, in resource-scarce countries, individuals outside of clinical trials may not have access to those treatments. This blog post from Ruth [...] Read more

14
Aug2012

by Avery Avrakotos, Education and Policy Coordinator

Preparations for the 2012 Advancing Ethical Research (AER) Conference  are gearing up, and I for one am getting excited about the annual poster presentations. To channel my excitement, I reached out to some of our past presenters to find out what they have been up to. This week, I chatted with Amal Matar, PRIM&R’s 2010 Pillar of PRIM&R Award recipient, to see how her work has progressed since she shared her work at the 2011 AER [...] Read more

8
Aug2012

by Henry Silverman, MD, MA, professor of medicine, chair of the ethics advisory committee, and director of the Middle East Research Ethics Training Initiative at the University of Maryland School of Medicine

For more than 10 years, the Fogarty International Center at the National Institutes of Health (NIH) has funded several educational programs that aim to strengthen research bioethics expertise in in low- and middle-income countries (LMICs).  Such programs offer intensive education on research ethics to in-country academics who then can enhance local ethics review of research, develop [...] Read more

1
Aug2012

by Avery Avrakotos, Education and Policy Coordinator

Preparations for the 2012 Advancing Ethical Research (AER) Conference are gearing up, and I, for one, am getting excited about the annual poster presentations. To channel my excitement, I reached out to past presenter Brandon Brown to see how his work has progressed since he shared his poster  at the 2011 AER Conference.
Read more

27
Jul2012

Recent changes to clinical trial rules in Europe, an emerging controversy over Food and Drug Administration (FDA)-approved anemia drugs, and heated debate over the bird flu moratorium are all in the mix in this week’s Research Ethics Roundup.

Europe proposes revision of clinical trial rules: The European Commission has formally adopted proposals for new rules to replace the controversial Clinical Trials Directive. Experts predict that these changes will reduce some of the red tape that has resulted in bloated insurance costs and a reduction in the number of clinical trials being conducted in the EU since the inception of the directive.